ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1429–1440 of 2020 project topics
RASopathy Carrier Screening and Risk Stratification Tool
A digital health platform enabling prenatal and preconception genetic counseling by identifying carriers of RASopathy-associated genes and calculating inheritance risk in family planning scenarios. Insurance companies, fertility clinics, and reproductive health networks adopt this tool to offer value-added genetic risk assessment services, expanding addressable markets and improving patient retention.
Genetic Basis of RASopathies Click to view more details →
Real-World RASopathy Outcomes Registry and Analytics Suite
A cloud-native registry platform that aggregates genotype, phenotype, and clinical outcomes data from RASopathy patients across multiple healthcare systems with HIPAA-compliant analytics and visualization tools. Pharmaceutical sponsors, contract research organizations, and precision medicine companies license access to this longitudinal dataset for clinical trial recruitment, real-world evidence generation, and therapeutic development validation.
Genetic Basis of RASopathies Click to view more details →
JAK2 V617F and Exon 12 Myeloproliferative Testing
Developing sensitive JAK2 V617F allele-specific PCR and exon 12 sequencing for diagnosing polycythemia vera and monitoring clonal burden.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
Primary Familial Congenital Polycythemia EPOR Testing
Characterizing EPOR gain-of-function variants causing hypersensitivity to erythropoietin in primary familial and congenital polycythemia.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
VHL Chuvash Polycythemia Variant Analysis
Identifying VHL R200W and other variants causing Chuvash polycythemia through impaired hypoxia response regulation.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
Hereditary High Altitude Adaptation Genetics
Investigating EPAS1 and EGLN1 variants enabling high altitude adaptation in Tibetan and Andean populations for understanding erythropoiesis regulation.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
EPAS1 HIF-2α Hypoxia Pathway Commercial Testing Platform
A diagnostic SaaS platform that sequences and analyzes EPAS1 gene variants affecting HIF-2α signaling in erythrocytosis patients for precise phenotype stratification. This tool enables laboratories to offer differentiated testing services, reducing turnaround time by 40% and creating recurring revenue through subscription-based variant interpretation subscriptions.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
PHD2 EGLN1 Gene Mutation Detection Commercial Assay Kit
An industry-grade molecular testing kit that identifies PHD2 (EGLN1) loss-of-function mutations driving congenital erythrocytosis with automated reporting software. This product captures the emerging segment of genetic screening for familial polycythemia, generating B2B revenue through hospital and diagnostic laboratory partnerships.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
Secondary Erythrocytosis Differential Diagnosis AI-Powered Platform
An intelligent clinical decision support platform that integrates genetic, hematologic, and imaging data to differentiate between myeloproliferative and secondary erythrocytosis causes. This SaaS solution monetizes through per-test fees and enterprise licenses, reducing diagnostic uncertainty and improving physician confidence in treatment selection.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
EGLN1 PHD2 and EGLN3 Rare Variant Commercial Panel
A comprehensive next-generation sequencing panel targeting rare oxygen-sensing pathway genes (PHD2, PHD3, FIH1) for polycythemia genetic profiling. The service generates revenue through premium pricing for rare variant interpretation and longitudinal patient monitoring subscriptions across specialty hematology centers.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
Erythropoietin Signaling Pathway Genomic Risk Stratification Tool
A commercial bioinformatics platform that analyzes germline variants in EPO-EPOR signaling genes to predict erythrocytosis severity and progression risk. This tool monetizes through licensing agreements with pharmaceutical companies developing targeted therapies and direct-to-consumer genetic testing partnerships.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →
Congenital Polycythemia Multi-Gene Sequencing Diagnostic Service
An outsourced molecular diagnostics service offering targeted sequencing of all known congenital erythrocytosis genes (EPOR, EPAS1, PHD2, PHD3, FIH1) with clinical variant interpretation. This managed service model generates recurring revenue through per-sample processing fees and consultation services for complex genotype-phenotype correlations.
Genetic Basis of Polycythemia and Erythrocytosis Click to view more details →